Harmony Biosciences Holdings, Inc.(HRMY),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

HRMY Harmony Biosciences Holdings, Inc.

Trading 11-04 15:53:03 EST

34.37

-2.65

-7.16%

High35.86	Low32.61	Vol2.11M
Open34.50	D1 Closing37.02	Amplitude8.78%
Mkt Cap2.00B	Tradable Cap1.79B	Total Shares58.24M
T/O72.16M	T/O Rate4.05%	Tradable Shares52.10M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"HRMY","market":"US","secType":"STK","nameCN":"Harmony Biosciences Holdings, Inc.","latestPrice":34.37,"timestamp":1793825579093,"preClose":37.02,"halted":0,"volume":2109532,"delay":0,"changeRate":-0.07158292814694775,"floatShares":52095000,"shares":58236393,"eps":3.09102,"marketStatus":"Trading","change":-2.65,"latestTime":"11-04 15:53:03 EST","open":34.5,"high":35.86,"low":32.61,"amount":72157961.77503599,"amplitude":0.08779,"askPrice":34.38,"askSize":101,"bidPrice":34.34,"bidSize":200,"shortable":0,"etf":0,"ttmEps":3.09102,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1793826000000},"marketStatusCode":2,"adr":0,"listingDate":1597809600000,"exchange":"NASDAQ","adjPreClose":37.02,"preHourTrading":{"tag":"盘前","latestPrice":34.43,"preClose":37.02,"latestTime":"09:29 EST","volume":25183,"amount":875151.0537800001,"timestamp":1793802599999,"change":-2.59,"changeRate":-0.069962,"amplitude":0.149649},"postHourTrading":{"tag":"盘后","latestPrice":36.4988,"preClose":37.02,"latestTime":"19:57 EST","volume":42169,"amount":1560386.7446,"timestamp":1793753838624,"change":-0.5212,"changeRate":-0.014079,"amplitude":0.074857},"volumeRatio":2.103676,"impliedVol":0.705,"impliedVolPercentile":0.8845},"requestUrl":"/m/hq/s/HRMY/tweets","defaultTab":"tweets","newsList":[{"id":"2680050609","title":"Harmony Biosciences Holdings, Inc. Reports Results for the Quarter Ended September 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2680050609","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680050609?lang=en_us&edition=fundamental","pubTime":"2026-11-04 22:32","pubTimestamp":1793802731,"startTime":"0","endTime":"0","summary":"Harmony Biosciences Holdings, Inc. reports results for the quarter ended September 30 - Earnings SummaryHarmony Biosciences Holdings, Inc.HRMY.OQreported quarterly adjusted earnings of 81 cents per sh","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261104:nL5N46L25P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HRMY","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680059177","title":"Harmony Biosciences Shares Down 5.7% Premarket After Q3 Revenue, Pretax Profit Miss","url":"https://stock-news.laohu8.com/highlight/detail?id=2680059177","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680059177?lang=en_us&edition=fundamental","pubTime":"2026-11-04 20:47","pubTimestamp":1793796452,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261104:nL3N46L1ES:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","HRMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680059956","title":"Earnings Flash (HRMY) Harmony Biosciences Posts Q3 EPS $0.81, vs. FactSet Est of $1.09","url":"https://stock-news.laohu8.com/highlight/detail?id=2680059956","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680059956?lang=en_us&edition=fundamental","pubTime":"2026-11-04 20:39","pubTimestamp":1793795947,"startTime":"0","endTime":"0","summary":"Earnings Flash (HRMY) Harmony Biosciences Posts Q3 EPS $0.81, vs. FactSet Est of $1.09","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["HRMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680505980","title":"Harmony Biosciences Q3 Net Income Falls 5% Year over Year to USD 48.2 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2680505980","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680505980?lang=en_us&edition=fundamental","pubTime":"2026-11-04 20:36","pubTimestamp":1793795817,"startTime":"0","endTime":"0","summary":"Harmony Biosciences Q3 net income falls 5% year over year to USD 48.2 millionHarmony Biosciences’ Q3 2026 diluted earnings per share fell 7% year-over-year to USD 0.81.Net product revenue climbed 12% ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261104:nNDL6LszZQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HRMY","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680567090","title":"Harmony Biosciences Q3 EPS $0.81 Misses $1.10 Estimate, Sales $268.917M Miss $273.078M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2680567090","media":"Benzinga Earnings","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680567090?lang=en_us&edition=fundamental","pubTime":"2026-11-04 20:33","pubTimestamp":1793795610,"startTime":"0","endTime":"0","summary":"Harmony Biosciences (NASDAQ:HRMY) reported quarterly earnings of $0.81 per share which missed the analyst consensus estimate of $1.10 by 26.36 percent. This is a 25 percent decrease over earnings of $1.08 per share from","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"11c8fbbf839f433c9d274cef5f173382","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/11/62860537/harmony-biosciences-q3-eps-0-81-misses-1-10-estimate-sales-268-917m-miss-273-078m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","HRMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680056051","title":"Harmony Biosciences Names Peter Anastasiou President and CEO Effective Jan. 1, 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2680056051","media":"Reuters","labels":["executive","policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680056051?lang=en_us&edition=fundamental","pubTime":"2026-11-04 20:33","pubTimestamp":1793795610,"startTime":"0","endTime":"0","summary":"Harmony Biosciences Names Peter Anastasiou President and CEO Effective Jan. 1, 2027Harmony Biosciences named Peter Anastasiou president and CEO effective Jan. 1, 2027.Anastasiou, currently senior exec","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261104:nNDL7kMVLS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014013.SGD","NDAQ","HRMY","IE00BKPKM429.USD","IE00BQXX3F31.USD","IE00BGHQF748.EUR","LU0314104364.USD","LU2210149790.SGD","IE00BN0W2W23.USD","SG9999014005.SGD","IE00BN0W2V16.EUR","BK4112","IE00B3QW5Z07.USD","LU2095319765.USD","IE00BN0W2T93.GBP","LU2210150020.SGD","SG9999014039.USD","BK4007","BK4588","BCDF","BK4585","SG9999014021.USD","IE00B64PRP62.GBP","IE00BQXX3C00.GBP","IE00BQXX3D17.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680772056","title":"Harmony Biosciences - Pitolisant Hd Phase 3 Topline Data Expected in 2027; Target Pdufa Date in 2028","url":"https://stock-news.laohu8.com/highlight/detail?id=2680772056","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680772056?lang=en_us&edition=fundamental","pubTime":"2026-11-04 20:30","pubTimestamp":1793795402,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261104:nPLX6ZB559:7","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HRMY","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680105642","title":"Harmony Biosciences Q3 Operating Income USD 54.197 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2680105642","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680105642?lang=en_us&edition=fundamental","pubTime":"2026-11-04 20:30","pubTimestamp":1793795402,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261104:nPLX6ZB559:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HRMY","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680056779","title":"Harmony Biosciences - Pitolisant Gr Nda Under FDA Review; Pdufa Date April 1, 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2680056779","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680056779?lang=en_us&edition=fundamental","pubTime":"2026-11-04 20:30","pubTimestamp":1793795402,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261104:nPLX6ZB559:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HRMY","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680056423","title":"Harmony Biosciences Q3 Gross Profit USD 188.231 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2680056423","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680056423?lang=en_us&edition=fundamental","pubTime":"2026-11-04 20:30","pubTimestamp":1793795402,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261104:nPLX6ZB559:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HRMY","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680056478","title":"Harmony Biosciences Reports Q3 Financial Results on Track to Achieve More than $1 Billion Wakix Net Revenue and Announces Strong Multiple-Ascending Dose Data for Its Orexin Agonist BP-205, Supporting Potential Best-in-Class Profile","url":"https://stock-news.laohu8.com/highlight/detail?id=2680056478","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680056478?lang=en_us&edition=fundamental","pubTime":"2026-11-04 20:30","pubTimestamp":1793795402,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261104:nTUABXV8VQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HRMY","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679474992","title":"Harmony Biosciences Sets Incoming CEO Peter Anastasiou's Annual Base Salary at $725,000","url":"https://stock-news.laohu8.com/highlight/detail?id=2679474992","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2679474992?lang=en_us&edition=fundamental","pubTime":"2026-10-31 04:15","pubTimestamp":1793391351,"startTime":"0","endTime":"0","summary":"Harmony Biosciences Sets Incoming CEO Peter Anastasiou's Annual Base Salary at $725,000Harmony Biosciences clarified compensation arrangements for its CEO transition in an amended filing dated October","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261030:nNDLc9grFQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","HRMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173004053","title":"Earning Preview: Harmony Biosciences Holdings, Inc. this quarter’s revenue is expected to increase by 22.08%, and institutional views are cautiously positive","url":"https://stock-news.laohu8.com/highlight/detail?id=1173004053","media":"Earnings Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173004053?lang=en_us&edition=fundamental","pubTime":"2026-10-28 23:48","pubTimestamp":1793202526,"startTime":"0","endTime":"0","summary":"Abstract Harmony Biosciences Holdings, Inc. will report its quarterly results on November 04, 2026 Pre-MKt; this preview summarizes the latest revenue, margin, net profit and adjusted EPS trends,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Earning Preview: Harmony Biosciences Holdings, Inc. this quarter’s revenue is expected to increase by 22.08%, and institutional views are cautiously positive","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HRMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678174819","title":"Harmony Biosciences: Buy Rating Reiterated as Patent Strength and Clinical Catalysts Support Blockbuster WAKIX Profile; $55 Price Target Maintained","url":"https://stock-news.laohu8.com/highlight/detail?id=2678174819","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678174819?lang=en_us&edition=fundamental","pubTime":"2026-10-27 19:36","pubTimestamp":1793100965,"startTime":"0","endTime":"0","summary":"Patrick Trucchio, an analyst from H.C. Wainwright, reiterated the Buy rating on Harmony Biosciences Holdings. The associated price target remains t...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/harmony-biosciences-buy-rating-reiterated-as-patent-strength-and-clinical-catalysts-support-blockbuster-wakix-profile-55-price-target-maintained-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/harmony-biosciences-buy-rating-reiterated-as-patent-strength-and-clinical-catalysts-support-blockbuster-wakix-profile-55-price-target-maintained-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HRMY","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677091980","title":"Revisiting Former Stock Picks Marriott, Logitech, Harmony Biosciences","url":"https://stock-news.laohu8.com/highlight/detail?id=2677091980","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677091980?lang=en_us&edition=fundamental","pubTime":"2026-10-22 12:19","pubTimestamp":1792642740,"startTime":"0","endTime":"0","summary":"Looking back on stock picks forces accountability and shows which ideas actually held up. Markets change and only an honest review separates durable analysis from luck or bad timing. This can improve ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MAR","LU0154245673.USD","GB00B4QBRK32.GBP","BK4534","LU0154245756.USD","IE00B45NX917.SGD","LU0690374961.EUR","BK4007","BK4170","LU2764262908.HKD","LU0823411888.USD","LU1718418525.SGD","LU0950375773.USD","LU2404859667.USD","IE00B95QR487.USD","BK4524","LU0690374615.EUR","LU0823417653.USD","HLT","IE00BD0PCF45.HKD","BK4566","HRMY","LU2506952170.USD","LU0061475181.USD","LU2764263203.CNY","IE00B0T0GQ85.USD","LU1366192091.USD","LU2764263039.SGD","PEJ","LU2404859741.USD","LU0170899867.USD","BK4588","BK4585","BK4142","LU2720916845.USD","GB00B4LPDJ14.GBP","LU2506951875.HKD","LU2506951958.HKD","LU2506952097.USD","LU0823417737.USD","IE00B1G9WX41.USD","LOGI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676168356","title":"Analysts Offer Insights on Healthcare Companies: Harmony Biosciences Holdings (HRMY) and Zai Lab (ZLAB)","url":"https://stock-news.laohu8.com/highlight/detail?id=2676168356","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2676168356?lang=en_us&edition=fundamental","pubTime":"2026-10-19 19:40","pubTimestamp":1792410008,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Harmony Biosciences Holdings (HRMY) and Zai Lab (ZLA...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-harmony-biosciences-holdings-hrmy-and-zai-lab-zlab-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-harmony-biosciences-holdings-hrmy-and-zai-lab-zlab-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4548","BK4588","HCSG","HRMY","LU2488822045.USD","BK4526","BK4585","LU0128526141.USD","BK4007","XBI","LU0029874061.USD","BK4531","BK4139","BK4581","XLV","ZLAB","LABU","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676507299","title":"Harmony Biosciences Price Target Maintained with a $50.00/Share by Needham","url":"https://stock-news.laohu8.com/highlight/detail?id=2676507299","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2676507299?lang=en_us&edition=fundamental","pubTime":"2026-10-19 18:36","pubTimestamp":1792406160,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/HRMY/analyst-ratings","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","HRMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674480535","title":"Mizuho positive on Harmony Biosciences CEO transition","url":"https://stock-news.laohu8.com/highlight/detail?id=2674480535","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674480535?lang=en_us&edition=fundamental","pubTime":"2026-10-12 22:20","pubTimestamp":1791814810,"startTime":"0","endTime":"0","summary":"After Harmony Biosciences (HRMY) announced that Peter Anastasiou, the company’s current COO, will become President, CEO and a board member, Mizuho ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/mizuho-positive-on-harmony-biosciences-ceo-transition-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/mizuho-positive-on-harmony-biosciences-ceo-transition-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HRMY","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674808002","title":"Harmony Biosciences Price Target Maintained with a $50.00/Share by Needham","url":"https://stock-news.laohu8.com/highlight/detail?id=2674808002","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674808002?lang=en_us&edition=fundamental","pubTime":"2026-10-12 21:37","pubTimestamp":1791812220,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/HRMY/analyst-ratings","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","HRMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674811808","title":"US Stocks on the MOVE-Salesforce, Brown & Brown, IonQ, Harmony Biosciences","url":"https://stock-news.laohu8.com/highlight/detail?id=2674811808","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674811808?lang=en_us&edition=fundamental","pubTime":"2026-10-12 21:03","pubTimestamp":1791810185,"startTime":"0","endTime":"0","summary":"BUZZ-US STOCKS ON THE MOVE-Salesforce, Brown & Brown, IonQ, Harmony BiosciencesOct 12 (Reuters)-US stock indexes were on track for a muted open on Monday as investors watched oil prices and global eve","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261012:nL4N45Y0RE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1291159041.SGD","LU1670710661.SGD","IREG","LU0081259029.USD","LU0742534661.SGD","LU1201861165.SGD","LU0528227936.USD","LU2458330169.SGD","LU2264538146.SGD","IONC","LU2756315664.SGD","STCE","IREN","LU0238689110.USD","BK4533","LU0048573561.USD","LU1868836591.USD","LU0868494617.USD","LU1267930227.SGD","LU0354030438.USD","IE00BZ1G4Q59.USD","BRO","LU0198837287.USD","FTXH","LU1823568750.SGD","LU2461242641.AUD","LU1989764748.USD","BK4007","LU1366333091.USD","IREC","LU2210150020.SGD","LU0820561818.USD","LU0106261372.USD","LU0130517989.USD","LU0642271901.SGD","CRM","GDDY","LU1670711040.USD","IE00BKVL7J92.USD","LU1791710582.SGD","IBLC","LU1093756325.SGD","IE00BQXX3F31.USD","LU1951198990.SGD","LU2242652126.USD","IE00BSNM7G36.USD","BKCH","LU0052756011.USD","LU0648000940.SGD","BK4608","LU0477156797.USD","LU0882574055.USD","IE0009355771.USD","LU1032466523.USD","BK4588","BK4591","LU1236620750.USD","LU0211326839.USD","LU0225771236.USD","LU0477156953.USD","LU0109392836.USD","LU1718418525.SGD","LU1880398554.USD","LU1989771016.USD","BMY","LU0109394709.USD","LU0306807586.USD","LU1261432733.SGD","LU0957808578.USD","LU2210149790.SGD","LU2361045086.USD","IE00BJJMRZ35.SGD","BK4141","LU0943347566.SGD","BK4561","BK4516","LU0225284248.USD","LU0496365809.HKD","BK4173","BITQ","IONZ","DAPP","CRMG","IE00B2B36J28.USD","BK4600","LU0267386448.USD","QTUP","LU0006306889.USD","IE0002141913.USD","LU1988902786.USD","BIIB","LU0251142724.SGD","LU0433182093.SGD","LU0472753341.HKD","LU0354030511.USD","BK4598","WGMI","LU0096364046.USD","LU1951200564.SGD","BK4139","FDIG","LU1093756168.USD","LU1868837300.USD","LU1201861249.SGD","LU0353189680.USD","LU2596442595.SGD","LU2108987350.USD","BK4505","LU1868837136.USD","LU0068578508.USD","LU0187121727.USD","LU0321505868.SGD","LU0211326755.USD","IE00BKPKM429.USD","LU0792757196.USD","IONX","LU2458330243.SGD","LU1323610961.USD","LU2361044949.HKD","LU0069063385.USD","LU0124676726.USD","LU0130102774.USD","LU0353189763.USD","LU0476273544.USD","BK4096","LU0057025933.USD","LU1046421795.USD","LU2242646821.SGD","BK4543","LU0557290698.USD","MNRS","LU1496350502.SGD","LU1803068979.SGD","BMED","BK4550","LU0689626769.HKD","BK4023","CQTM","LU2491049909.HKD","BK4532","LU0114720955.EUR","LU2491050071.SGD","WQTM","BK4567","BK4559","BK4597","BK4613","LU0211331839.USD","LU1983299246.USD","LU0889566641.SGD","DCH","LU0251131958.USD","LU0234572021.USD","LU0878866978.SGD","IE00B19Z9505.USD","LU0444971666.USD","LU2265009873.SGD","LU0211328371.USD","LU2491050154.USD","IE00B19Z9Z06.USD","IONQ","LU1489326972.SGD","IOYY","LU0889565916.HKD","LU1074936037.SGD","LU1883839398.USD","IE00B19Z8W00.USD","LU0320765992.SGD","BK4548","BK4585","IHE","BK4595","LU1316542783.SGD","LU1720051017.SGD","LU2756315318.SGD","LU2361044865.SGD","LU0648001328.SGD","LU0985481810.HKD","BK4602","IRE","LU0130518102.USD","BK4534","LU0985489474.SGD","BK4579","LU1548497426.USD","LU2125154935.USD","LU2133065610.SGD","BK4528","IE00BFXG1179.USD","BK4607","LU0130103400.USD","LU0289739343.SGD","LU2247934214.USD","LU0082616367.USD","LU2357305700.SGD","LU1868836914.USD","LU0061475181.USD","IREZ","LU1551013425.SGD","BK4581","IE00BQXX3D17.EUR","LU0820561909.HKD","LU0306806265.USD","LU0980610538.SGD","LU0157215616.USD","LU0511384066.AUD","LU1236620834.HKD","IONL","LU1551013342.USD","LU1670711123.USD","LU1791710400.SGD","LU1804176565.USD","LU2087625088.SGD","LU1267930490.SGD","LU0976567544.SGD","LU1720051108.HKD","LU1868836757.USD","LU0127658192.USD","LU0719512351.SGD","ENVX","IE0008368304.USD","HRMY","IE00B894F039.SGD","LU0444973449.USD","LU0211327993.USD","LU2244417387.USD","LU0289961442.SGD","LU2286300806.USD","BK4124","LU2125154778.USD","LU1814569148.SGD","LU0689472784.USD","PBE","LU0432979614.USD","LU1571399168.USD","LU2095319765.USD","TRAX","IE00BQXX3C00.GBP","IE00B19Z8X17.USD","LU2236285917.USD","LU0456855351.SGD","LU1880398471.USD","LU1064131342.USD","LU1815336760.USD","IREX","LU0820562030.AUD","LU0314104364.USD","LU0237698245.USD","LU1923623000.USD","LU1235294995.USD","LU1670710588.SGD","LU0321505439.SGD","LU1430594728.SGD","LU2360032135.SGD","BK4116","LU0889565833.HKD","IE00BFTCPJ56.SGD","BK4538","LU1642822529.SGD","LU0128525689.USD","IE00B19Z9P08.USD","IE00BJTD4N35.SGD","BK4535","BK4170","LU1585245621.USD","LU0310799852.SGD","IE00BJTD4V19.USD","LU1989764664.SGD","LU1267930813.SGD","LU0234570918.USD","LU0310800965.SGD","IE00BJT1NW94.SGD","LU1496350171.SGD","BK4527"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.harmonybiosciences.com","stockEarnings":[{"period":"1week","weight":-0.0245},{"period":"1month","weight":-0.0661},{"period":"3month","weight":-0.0319},{"period":"6month","weight":0.1782},{"period":"1year","weight":0.2622},{"period":"ytd","weight":-0.0107}],"compareEarnings":[{"period":"1week","weight":-0.0199},{"period":"1month","weight":-0.0199},{"period":"3month","weight":-0.0201},{"period":"6month","weight":0.0311},{"period":"1year","weight":0.1039},{"period":"ytd","weight":0.1062}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. It offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania.","yearOnYearQuotes":[{"month":1,"riseRate":0.166667,"avgChangeRate":-0.035612},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.051691},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.016911},{"month":4,"riseRate":0.166667,"avgChangeRate":-0.04592},{"month":5,"riseRate":0.666667,"avgChangeRate":0.043963},{"month":6,"riseRate":0.666667,"avgChangeRate":0.019037},{"month":7,"riseRate":0.666667,"avgChangeRate":0.02924},{"month":8,"riseRate":0.833333,"avgChangeRate":0.069105},{"month":9,"riseRate":0.428571,"avgChangeRate":-0.020497},{"month":10,"riseRate":0.571429,"avgChangeRate":-0.007287},{"month":11,"riseRate":0.714286,"avgChangeRate":0.083879},{"month":12,"riseRate":0.5,"avgChangeRate":0.02881}],"exchange":"NASDAQ","name":"Harmony Biosciences Holdings, Inc.","nameEN":"Harmony Biosciences Holdings, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.52.1","shortVersion":"4.52.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Harmony Biosciences Holdings, Inc.(HRMY),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Harmony Biosciences Holdings, Inc.(HRMY) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Harmony Biosciences Holdings, Inc.,HRMY,Harmony Biosciences Holdings, Inc.股票,Harmony Biosciences Holdings, Inc.股票老虎,Harmony Biosciences Holdings, Inc.股票老虎国际,Harmony Biosciences Holdings, Inc.行情,Harmony Biosciences Holdings, Inc.股票行情,Harmony Biosciences Holdings, Inc.股价,Harmony Biosciences Holdings, Inc.股市,Harmony Biosciences Holdings, Inc.股票价格,Harmony Biosciences Holdings, Inc.股票交易,Harmony Biosciences Holdings, Inc.股票购买,Harmony Biosciences Holdings, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Harmony Biosciences Holdings, Inc.(HRMY),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Harmony Biosciences Holdings, Inc.(HRMY) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction